These results show both a decrease in overall IVC filter placement, as well as an increase in overall IVC filter retrieval at our institution. These trends are predominantly owing to a decrease in prophylactic filter placement as well as an overall increase in filter retrieval. Further study should be dedicated to increasing the retrieval rate in this patient population. Objectives: Carotid artery stenting (CAS) was introduced as an alternative carotid revascularization procedure in patients deemed high-risk for carotid endarterectomy. Although techniques and patient selection criteria have dramatically improved, CAS continues to have higher risk of stroke and death in comparison with carotid endarterectomy. Several risk factors are known to be associated with worse outcomes. Although knowledge of these independent factors is helpful, clinical decision making is further refined when these are considered in aggregate. Therefore, 
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the purpose of this study is to develop a score to predict the risk of stroke/ death after CAS. Methods: We analyzed the Vascular Quality Initiative dataset from 2009 to the present. Univariate and multivariate methods were used to identify predictors associated with 30-day stroke/death. Logistic regression was performed and variable selection for the final model was made on backward stepwise selection to achieve model parsimony. This final model was validated by bootstrapping (1000 repetitions) and tested by calibration (Hosmer-Lemeshow) and discrimination (c-statistic). A risk score was made by converting regression coefficients for each predictor to integers from which probability (%) was calculated. Scores were grouped into five simplified categories.
Results: We identified 11,479 patients who underwent CAS during the study period with a combined 30-day stroke/death rate of 3.8%. Patients who developed the outcome of 30-day stroke/death were older (median age, 75 years vs 72 years), more likely to be female (41.3% vs 35.8%), symptomatic (58% vs 40.1%), and diabetic (44.8% vs 37.4%), and less likely to be on statins (71.4% vs 81.8%) and antiplatelet agents (aspirin, 78.1% vs 86.8%; P2Y12-inhibitor, 61.8% vs 77.1%; all P < .05). The Table details the demographic variables, comorbidities, preoperative medication, and lesionspecific predictors that were analyzed. Independent predictors included in the final model were age, female gender, diabetes, coronary artery disease, chronic kidney disease, chronic obstructive pulmonary disease, symptomatic status, contralateral occlusion, restenotic lesion, preoperative statin use, and P2Y12-inhibitor use. The model had a c-statistic of 70.9%. The corresponding score for each predictor, risk of 30-day stroke/death and two examples are shown in the Fig. Conclusions: This study introduces an easy to use clinical tool for predicting stroke/death after CAS and will help surgeons and patients in weighing the risks versus the benefits of performing this procedure. In asymptomatic patients with high predicted stroke/death risk, medical management might be the safer option. Objectives: There is conflicting evidence regarding the association of diabetes mellitus (DM) and insulin use on outcomes after carotid endarterectomy (CEA). Therefore, we sought to evaluate the risk of insulindependent DM (IDDM) and non-insulin-dependent DM (NIDDM) on 30-day outcomes after CEA.
Methods: We identified patients undergoing CEA from the TargetedVascular National Surgical Quality Improvement Program (2011 Program ( -2015 and stratified patients based on their preprocedural symptom status. We compared 30-day outcomes between nondiabetics and patients with NIDDM or IDDM, with 30-day stroke/death as a primary end point.
Results: Of 16,739 CEA patients, 9784 (58%) were asymptomatic, of whom 6720 (69%) had no diagnosis of DM, 1109 (11%) had IDDM, and 1955 (20%) had NIDDM. Of the 6955 symptomatic patients, 4982 (72%) had no diagnosis of DM, 810 (12%) had IDDM, and 1163 (17%) had NIDDM. Among asymptomatic patients, patients with IDDM experienced higher rates of 30-day stroke/death compared with those without DM (3.4% vs 1.5%; P < .001), whereas those with NIDDM experienced similar rates as those without DM (2.1% vs 1.5%; P ¼ .1). After adjustment, IDDM was associated with 30-day stroke/death in asymptomatic patients compared with patients without DM (odds ratio, 2.3; 95% confidence interval, 1.5-3.4; P < .001; Table) , but NIDDM was not (odds ratio, 1.4; 95% confidence interval, 1.0-2.1; P ¼ .1). In comparison, among symptomatic patients, those with IDDM and NIDDM experienced similar rates of 30-day stroke/death as patients without DM, with 4.9% versus 3.6% and 4.0% versus 3.6% (both P > .1). After adjustment, neither IDDM nor NIDDM CI, Confidence interval; IDDM, insulin-dependent diabetes mellitus; MI, myocardial infarction; NIDDM, non-insulin-dependent diabetes mellitus; OR, odds ratio. Adjusted for age, gender, race, dependent functional status, obesity, smoking status, hypertension, congestive heart failure, chronic obstructive pulmonary disease, dialysis, anemia, contralateral carotid occlusion, preoperative betablocker or statin medication, any physiological or anatomic high-risk factor, preprocedural stroke (among symptomatic patients).
